OverviewThe global NLP in healthcare and life sciences market is witnessing rapid expansion and is expected to grow at an ...

Camzyos has the potential to be the first pharmacological therapy for the treatment of oHCM in adolescents, addressing a high unmet need for this populationApplication based on positive results of ...

Late-breaking Phase II data highlight enicepatide’s (CT-388) efficacy and safety, reinforcing its potential to deliver best-in-class weight loss across a broad population of people living with ...

Pesticides. Mycotoxins. Fraudulent Lab Reports. Forged Certificates of Analysis. This Is the State-Licensed Cannabis and Hemp Supply Chain the Courts and DEA Just Handed a Federal Registration Pathway ...

Lysoway Therapeutics, a biopharmaceutical company developing small-molecule modulators of lysosomal ion channels, today ...

Synexis®, LLC, the leader in touchless, continuous pathogen control technology, today announced a strategic collaboration with Midwest Veterinary Supply to bring Synexis DHP® technology to animal ...

Independent qualitative KPIs across 48 RCM categories will help healthcare buyers prove platform performance before purchase\, measuring user experience, functional outcomes, workflow execution, ...

The Poison Pill defends against no legitimate threat; 3D's acquisition of additional shares is not aimed at seizing ...

Nature-Cide X2 Plus Selected as Preferred All-Natural SolutionAs Customer Demand Trends Toward Natural Pest Control Solutions, Mosquito Authority / Pest Authority Launches Company-Wide Initiative to ...

The global hemodynamic monitoring systems market is projected to witness steady growth during the forecast period, expanding ...

SAN DIEGO, CA / ACCESS Newswire / June 1, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to ...

Oral and poster presentations span three priority programs in breast, gynecologic, and gastrointestinal cancers, advancing ...